North America Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, and AndeXXa); End User (Hospital Pharmacies, Retail Pharmacies, and Others)
Market Introduction
Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.
Thus, the increasing prevalence of stroke is expected to create a significant demand for anticoagulant reversal drugs in the coming years, which is further anticipated to drive the anticoagulant reversal drug market.
Get more information on this report :
Market Overview and Dynamics
The anticoagulant reversal drug market in North America is expected to grow from US$ 414.7 million in 2019 to US$ 1,037.9 million by 2027; it is estimated to grow at a CAGR of 12.8% from 2019 to 2027. Rapidly progressing research activities in drug development of novel therapeutics across the world to counter the growing prevalence of cardiovascular diseases, such as atrial fibrillation is driving the growth of the anticoagulant reversal drugs market. There is always a need for innovative therapeutic approaches in the treatment of various cardiovascular indications. For instance, the study titled ‘Evaluation of andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) for reversal of rivaroxaban‐ and apixaban‐associated intracranial hemorrhages,’ published in February 2020, was conducted in Massachusetts General Hospital, to investigate the efficacy of andexanet alfa in the treatment of intracranial hemorrhages (ICH). This is bolstering the growth of the anticoagulant reversal drug market.
Key Market Segments
In terms of product, the vitamin K segment accounted for the largest share of the North America anticoagulant reversal drug market in 2019. In terms of distribution channel, the hospital pharmacies segment held a larger market share of the anticoagulant reversal drug market in 2019.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the anticoagulant reversal drug market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Boehringer Ingelheim International GmbH, Pfizer Inc, Octapharma AG, AMAG PHARMACEUTICALS, INC., Fresenius Kabi AG, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), CSL Limited, and Grifols, S.A.
Reasons to buy report
- To understand the North America anticoagulant reversal drug market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America anticoagulant reversal drug market
- Efficiently plan M&A and partnership deals in North America anticoagulant reversal drug market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America anticoagulant reversal drug market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
NORTH AMERICA ANTICOAGULANT REVERSAL DRUG MARKET SEGMENTATION
By Product
- Prothrombin Complex Concentrates
- Vitamin K
- Protamine
- Tranexamic Acid
- Idarucizumab
- AndeXXa
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Pfizer Inc
- Octapharma AG
- AMAG PHARMACEUTICALS, INC.
- Fresenius Kabi AG
- Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- CSL Limited
- Grifols, S.A.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Anticoagulant Reversal Drug Market – By Product
1.3.2 Anticoagulant Reversal Drug Market – By Distribution Channel
1.3.3 North America Anticoagulant Reversal Drug Market – By Country
2. North America Anticoagulant Reversal Drug Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Anticoagulant Reversal Drug Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anticoagulant Reversal Drug Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Anticoagulant Reversal Drug Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Atrial Fibrillation (AFib)
5.1.2 Increase in Prevalence of Stroke
5.2 Market Restraints
5.2.1 High Cost of Anticoagulant Reversal Drugs
5.3 Market Opportunities
5.3.1 Increasing Research Activities on Anticoagulant Reversal Drugs
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact Analysis
6. Anticoagulant Reversal Drug Market – North America Analysis
6.1 North America Anticoagulant Reversal Drug Market Revenue Forecasts and Analysis
7. North America Anticoagulant Reversal Drug Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
7.3 Prothrombin Complex Concentrates
7.3.1 Overview
7.3.2 Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.4 Vitamin K
7.4.1 Overview
7.4.2 Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.5 Protamine
7.5.1 Overview
7.5.2 Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.6 Tranexamic Acid
7.6.1 Overview
7.6.2 Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.7 Idarucizumab
7.7.1 Overview
7.7.2 Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.8 Andexxa
7.8.1 Overview
7.8.2 Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
8. North America Anticoagulant Reversal Drug Market Analysis and Forecasts to 2027– By Distribution Channel
8.1 Overview
8.2 Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
9. Anticoagulant Reversal Drug Market Revenue and Forecasts to 2027 – Geographical Analysis
9.1 North America: Anticoagulant Reversal Drugs Market
9.1.1 Overview
9.1.2 North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.1.3 US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.1 US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 US: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)
9.1.3.3 US: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)
9.1.4 Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.1 Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.2 Canada: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)
9.1.4.3 Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)
9.1.5 Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1 Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2 Mexico: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)
9.1.5.3 Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)
10. Impact Of COVID-19 Pandemic on North America Anticoagulant Reversal Drug Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.2.2 Organic Developments Done By Companies
11.3 Inorganic Developments
11.3.1 Overview
11.3.2 Inorganic Developments Done By Companies
Source: The Insight Partners Analysis, Website, Press Releases and Others
12. COMPANY PROFILES
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pfizer Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Octapharma AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AMAG PHARMACEUTICALS, INC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 CSL Limited
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Grifols, S.A.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. US Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 3. Canada Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 4. Canada Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. Mexico Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. Mexico Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. Glossary of Terms, Anticoagulant Reversal Drug Market
LIST OF FIGURES
Figure 1. Anticoagulant Reversal Drug Market Segmentation
Figure 2. North America Anticoagulant Reversal Drug Market Overview
Figure 3. Vitamin K Segment Held Largest Share of Product in Anticoagulant Reversal Drug Market
Figure 4. Hospital Pharmacies Segment Held Largest Share of Distribution Channel in Anticoagulant Reversal Drug Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Anticoagulant Reversal Drug Market - North America PEST Analysis
Figure 7. Anticoagulant Reversal Drug Market Impact Analysis of Driver and Restraints
Figure 8. North America Anticoagulant Reversal Drug Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 1. Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
Figure 2. Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 3. Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 4. Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 5. Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 6. Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 7. Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 8. Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 9. Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 10. Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 11. Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 12. North America: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)
Figure 13. North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 14. US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 15. Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 16. Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 17. Impact of COVID-19 Pandemic in North American Country Markets
Figure 18. Growth Strategies Done by the Companies in the Market, (%)
- Boehringer Ingelheim International GmbH
- Pfizer Inc
- Octapharma AG
- AMAG PHARMACEUTICALS, INC.
- Fresenius Kabi AG
- Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- CSL Limited
- Grifols, S.A.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America anticoagulant reversal drug market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America anticoagulant reversal drug market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the anticoagulant reversal drug market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution